Nuwan Sameera Liyanage

Mr. Nuwan Sameera Liyanage

Université du Québec à Trois-Rivières, Trois-Rivières, Quebec, Canada

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 June 2022 in Biomolecules
Verified
Journal Article
Open access
PDF file
MKManoj Koirala
Manoj Koirala
VKVahid Karimzadegan
Vahid Karimzadegan
NLNuwan Sameera Liyanage
Nuwan Sameera Liyanage
NMNatacha Merindol
Natacha Merindol
IDIsabel Desgagne-Penix
Isabel Desgagne-Penix
Amaryllidaceae alkaloids (AAs) are plant specialized metabolites with therapeutic properties exclusively produced by the Amaryllidaceae plant family. The two most studied representatives of the family are galanthamine, an acetylcholinesterase inhibitor used as a treatment of Alzheimer’s disease, and lycorine, displaying potent in vitro and in vivo cytotoxic and antiviral properties. Unfortunately, the variable level of AAs’ production in planta restricts most of the pharmaceutical applications. Several biotechnological alternatives, such as in vitro culture or synthetic biology, are being developed to enhance the production and fulfil the increasing demand for these AAs plant-derived drugs. In this review, current biotechnological approaches to produce different types of bioactive AAs are discussed.